Higher expression is linked with some cancers (AHRR, DSC2) [59, 60], poorer prognosis of lung cancer (P2RY6) [55], and cardiovascular diseases (GPR15, DCS2) [61, 62]. This evidence concerns the gene DSC2 and lung carcinoma.